TB-500: Mechanism, Safety, and Regulatory Overview

An abstract watercolor illustration of a 7-link peptide chain. The chain is composed of connected hexagonal shapes, transitioning from green on the ends to a glowing yellow-orange in the middle. The background is a soft blend of light green and yellow with small, colorful speckles, resembling a subtle bokeh effect.

TB-500: Mechanism, Safety & Regulatory Guide

The content on this page is for general informational and educational purposes only and is not intended as medical advice, a recommendation, or an endorsement of any specific medication, treatment, or health product. Always consult a qualified healthcare provider before making decisions about medications, supplements, or changes to your health regimen. BodySpec does not prescribe, dispense, promote, offer, sell, or facilitate access to any of the pharmaceutical products discussed below.

Have you ever wondered how a fragment of a naturally occurring protein might speed up tissue repair—despite no human trials to back it?

TB-500 is a synthetic heptapeptide (a peptide composed of seven amino acids) fragment of thymosin beta-4, catalogued under PubChem CID 62707662 (PubChem, 2026). Early animal and in vitro studies have investigated its potential for wound healing, cell migration, and angiogenesis.

Yet while early data hint at real potential, teasing apart TB-500’s cellular actions and its evolving legal status calls for a closer look.

A watercolor illustration depicts a green, cloud-like protein structure breaking a yellow chain-like peptide fragment, represented by orange lightning bolts and green particles scattering.

What Is TB-500?

Thymosin beta-4 is an endogenous, 43-amino acid protein that regulates actin dynamics—the processes that control cell movement and structure—and supports wound repair (UniProt, 2026). TB-500 is a 7-amino acid peptide fragment (Ac-LKKTETQ) representing the protein’s core actin-binding domain. It has a molecular weight of 889.0 g/mol and the formula C38H68N10O14 (PubChem, 2026). In the few published animal studies, TB-500 has been injected intraperitoneally, and its tissue distribution has not been characterized.

Mechanism of Action: Actin Modulation & Tissue Repair

A scoping review by McGuire et al. (2026) mapped the mechanisms studied for thymosin beta-4 (TB4) and TB-500, finding direct TB-500 evidence in only one of its 80 included studies:

  • Enhancing endothelial cell migration.
  • Promoting angiogenesis (the formation of new blood vessels), which may support oxygen and nutrient delivery to injury sites.
  • Modulating inflammatory signaling.
An illustration showing a large red blood vessel branching out into progressively smaller vessels that change color from red to orange, then yellow, and finally light green. Two small blue dots are visible within the yellow and green sections, and the text 'New Vessels' is below the illustration.

Potential Benefits & Preclinical Evidence

Preclinical models suggest TB-500 may support tissue repair:

  • Improves early Achilles tendon healing in rats (Biçer et al., 2026); muscle data are specific to full-length thymosin beta-4.
  • Shows wound-healing activity in vitro for the metabolite Ac-LKKTE, not TB-500 itself (Rahaman et al., 2024).

Despite these findings, no controlled human interventional trials have evaluated the TB-500 fragment (Ac-LKKTETQ) itself; the human trial data that exist are for full-length thymosin beta-4.

An abstract illustration of an ankle and foot, with a bright, glowing area around the Achilles tendon and ankle joint, representing healing or pain relief. The foot is depicted in warm tones, and the lower leg in cooler greenish tones, transitioning to yellow and green at the point of interest.

Dosage Considerations

No standardized human dosing guidelines exist for TB-500. In the one controlled rodent study, rats received TB-500 at 60 µg/kg/day intraperitoneally for four weeks (Biçer et al., 2026). Higher milligram-per-kilogram figures sometimes quoted come from studies of full-length thymosin beta-4, a different molecule. Any human regimen remains speculative—patients should consult a qualified healthcare provider before considering experimental frameworks.

Regulatory Status & Compliance

  • The FDA listed TB-500 in 503A Category 2 in late 2023; it was removed in April 2026 and remains ineligible for compounding (BSCG, 2026).
  • WADA prohibits TB-500 under section S2.3 (Growth Factors and Growth Factor Modulators) (World Anti-Doping Agency, 2026).
  • Military and collegiate drug-testing programs prohibit TB-500 under their own rules—the NCAA names it explicitly, and unapproved drugs require a prescription.
An illustration of a gold medal with the number '1' on it, crossed out by a red circle with a diagonal line, similar to a 'no' symbol. Below the medal, the word 'Banned' is written in black text. The background is a light, neutral color.

Ensuring Peptide Purity: Quality-Control Checklist

  • Certificate of Analysis confirming ≥ 95% purity.
  • Third-party testing for endotoxins, heavy metals, and microbial contaminants.
  • Certification through accredited programs such as BSCG Certified Drug Free.
  • Batch-specific HPLC or mass spectrometry chromatograms verifying sequence integrity.
  • Clear storage and handling instructions on labeling.

TB-500 vs. BPC-157 vs. Other Peptides

FeatureTB-500BPC-157Other Peptides
MechanismActin modulation, angiogenesisVEGF modulation, gut mucosal repairVaries by compound
Clinical EvidencePreclinical onlyAnimal studies, limited case reportsMinimal human data
Regulatory StatusUnapproved; removed from FDA Cat 2Research chemical (unapproved)Largely research chemicals
WADA ProhibitionS2.3 Growth Factor ModulatorS0 Non-Approved SubstanceDepends on classification
Primary UsesTissue repair, wound healingGI issues, tendon/ligament recoveryResearch, experimental
An illustration of a balance scale with 'TB-500' on the left side and 'BPC-157' on the right side, both suspended evenly, indicating a comparison or balance between the two.

Frequently Asked Questions

Is TB-500 legal for athletes? TB-500 is banned by WADA; athletes face sanctions for positive tests.

Are there human safety data? No controlled human trials have assessed TB-500’s safety profile.

What drives its wound-healing effects? An in vitro study suggests the metabolite Ac-LKKTE may be active (Rahaman et al., 2024).

Could TB-500 cause tumor growth? Thymosin beta-4 is overexpressed in colorectal cancer, correlating with metastasis and worse survival; relevance to TB-500 remains undetermined (Lee et al., 2017).

Where can I learn more about recovery protocols? See our guides on Soft Tissue Injury: Symptoms, Treatment, and Recovery and Muscle Recovery: A Science-Backed Guide to Heal Faster.

Conclusion

TB-500 remains an intriguing research chemical with preliminary preclinical support for promoting cellular migration and vascular repair pathways, yet it lacks human clinical validation and clear therapeutic approval. For those interested in understanding their body composition independent of peptide protocols, BodySpec DEXA scans offer precise, reproducible measurements of lean mass index, bone density, and overall body composition. Schedule a scan to establish an accurate baseline for your body composition journey.

Recommended articles
A pink bathroom scale with a coiled yellow measuring tape unspooling onto the scale. The scale reads '0 lb' and '0 kg'.
23 Mar
4 mins read
Ever Heard of the “Body Fat Index”? Here’s Why It’s More Important Than BMI.
A low angle view of a person in shorts and athletic shoes bending down with a barbell, preparing to lift it.
02 Nov
2 mins read
Lose Fat AND Gain Muscle - Is It Possible?
Water is being poured from above into a clear glass, splashing and filling the glass against a light blue background with water droplets on the surface below.
04 Oct
3 mins read
Will Drinking Water Affect My Scan?